• 一抗
  • 二抗
  • 慢病毒
  • 细胞系
  • 裂解物
  • 试剂类

WB-Validated AVEN Lentiviral shRNA Knockdown Kit #V61818

一键复制产品信息
RT-qPCR analysis. HT-1080 cells were infected with AVEN-specific shRNA lentiviral particles, total RNA was extracted from wild-type and knockdown cells, RT-qPCR was performed using gene-specific primers. ∆Ct (CtKD-CtWT) was used to calculate mRNA reduction (%) between wild-type and knockdown cells using the following formula: (1-1/2∆Ct) x 100%.
Western blotting analysis.AVEN protein expression in wild-type (WT) and shRNA knockdown (KD) HT-1080 cells was detected using Western blotting.  Hsp90 α served as a loading control. The blots were incubated with primary antibodies against AVEN and Hsp90 α, respectively, followed by incubating with HRP-conjugated goat anti-rabbit secondary antibody. Images were developed using NaQ™ ECL Substrate Kit.
  • 基因名:
    AVEN
  • 货号:
    V61818
  • 应用:
    Gene Knockdown (KD)
  • 物种反应性:
    H
规格:
1 Kit
价格:
8000
Information
Product Name WB-Validated AVEN Lentiviral shRNA Knockdown Kit
Aliases AVEN; Apoptosis And Caspase Activation Inhibitor; Cell Death Regulator Aven; PDCD12; Programmed Cell Death 12; Apoptosis, Caspase Activation Inhibitor
Background

Gene Name: AVEN

NCBI Gene Entry: 57099

Storage Store at -80 °C for one year.
Kit Components 1. WB-Validated AVEN shRNA lentiviral particles (4 mL)
2. Non-Target shRNA lentiviral particles (4 mL)
3. Verification Tool: KD-Validated Anti-AVEN Rabbit mAb#61818 (5 μL)
Tested Cell Line HT-1080
Validation Methods RT-qPCR; Western Blotting (WB)
Shipping Shipped with dry ice. Immediately store the product in a standard freezer at -80°C upon receipt.
Instructions For Use The following protocol uses HT-1080 cell as an example assuming your cell culture medium is DMEM-based.
1.Release 0.5 million HT-1080 cells into a 35 mm tissue culture dish in 2 mL of the growth medium (DMEM containing 10% FBS and 1% pen/strep). Cell density should reach 50-60% confluence the following day.
2.24 h after cell release, pre-warm the shRNA lentiviral medium to 37°C.
3.Discard 1 mL of the original growth medium of the 35 mm dish.
4.Using a serological pipette, gently mix the lentiviral solution 3 times.
5.Carefully add 1 mL of the lentiviral solution to the well. Tip: To prevent splashing, add the solution to the dish along the wall.
6.Add a polybrene stock solution to the culture medium at a final concentration of 5 μg/mL. Gently swirl the dish to mix.
7.48 h after cell release, without discarding the original medium, add another 1 mL of lentiviral medium directly into the dish.
8.Add an additional polybrene stock solution into the dish to obtain a final concentration of 5 μg/mL. Tip: Now, the medium in the dish should be a total of 3 mL.
9.72 h after cell release, cells may reach confluence. Trypsinize the cells off the 35 mm dish and culture those cells in a 60 mm dish.
10.Add puromycin to the dish at a final concentration of 4 μg/mL. Tip: To assess the efficacy of puromycin selection, culture a dish of wild-type HT-1080 cells as a negative control.
11.Allow puromycin selection for 48 h. Almost all wild-type HT-1080 cells should die, while the dish infected with lentiviruses should have some remaining cells.
12.Replace the medium with regular growth medium without puromycin and allow the cells to grow to confluence before harvesting or staining.
Note 1. This product is for research use only.
2. This product is only supplied to end users.
3. Do not use this product for commercial.
Picture
  • RT-qPCR analysis. HT-1080 cells were infected with AVEN-specific shRNA lentiviral particles, total RNA was extracted from wild-type and knockdown cells, RT-qPCR was performed using gene-specific primers. ∆Ct (CtKD-CtWT) was used to calculate mRNA reduction (%) between wild-type and knockdown cells using the following formula: (1-1/2∆Ct) x 100%.
  • Western blotting analysis.AVEN protein expression in wild-type (WT) and shRNA knockdown (KD) HT-1080 cells was detected using Western blotting.  Hsp90 α served as a loading control. The blots were incubated with primary antibodies against AVEN and Hsp90 α, respectively, followed by incubating with HRP-conjugated goat anti-rabbit secondary antibody. Images were developed using NaQ™ ECL Substrate Kit.
Citation(0)
RT-qPCR analysis. HT-1080 cells were infected with AVEN-specific shRNA lentiviral particles, total RNA was extracted from wild-type and knockdown cells, RT-qPCR was performed using gene-specific primers. ∆Ct (CtKD-CtWT) was used to calculate mRNA reduction (%) between wild-type and knockdown cells using the following formula: (1-1/2∆Ct) x 100%.
Western blotting analysis.AVEN protein expression in wild-type (WT) and shRNA knockdown (KD) HT-1080 cells was detected using Western blotting.  Hsp90 α served as a loading control. The blots were incubated with primary antibodies against AVEN and Hsp90 α, respectively, followed by incubating with HRP-conjugated goat anti-rabbit secondary antibody. Images were developed using NaQ™ ECL Substrate Kit.
  • 联系电话

    0551-63635518

    0551-65578998

  • 联系邮箱

    support@genuinbiotech.cn

    sales@genuinbiotech.cn

微信公众号

Copyright © 2025 合肥善本生物科技有限公司

All Rights Reserved. 皖ICP备2023000814号